Seuraa
Ewa Zeslawska
Ewa Zeslawska
Vahvistettu sähköpostiosoite verkkotunnuksessa up.krakow.pl
Nimike
Viittaukset
Viittaukset
Vuosi
Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents
A Schweinitz, T Steinmetzer, IJ Banke, MJE Arlt, A Sturzebecher, ...
Journal of Biological Chemistry 279 (32), 33613-33622, 2004
1672004
Crystals of the urokinase type plasminogen activator variant βc-uPA in complex with small molecule inhibitors open the way towards structure-based drug design
E Zeslawska, A Schweinitz, A Karcher, P Sondermann, S Sperl, ...
Journal of molecular biology 301 (2), 465-475, 2000
912000
Crystals of urokinase type plasminogen activator complexes reveal the binding mode of peptidomimetic inhibitors
E Zeslawska, U Jacob, A Schweinitz, G Coombs, W Bode, E Madison
Journal of molecular biology 328 (1), 109-118, 2003
482003
The 5-aromatic hydantoin-3-acetate derivatives as inhibitors of the tumour multidrug resistance efflux pump P-glycoprotein (ABCB1): Synthesis, crystallographic and biological …
E Żesławska, A Kincses, G Spengler, W Nitek, K Wyrzuc, ...
Bioorganic & Medicinal Chemistry 24 (12), 2815-2822, 2016
352016
Highly efficient microwave synthesis of rhodanine and 2-thiohydantoin derivatives and determination of relationships between their chemical structures and antibacterial activity
W Tejchman, B Orwat, I Korona-Głowniak, A Barbasz, I Kownacki, ...
RSC advances 9 (67), 39367-39380, 2019
282019
Pronounced activity of aromatic selenocyanates against multidrug resistant ESKAPE bacteria
MJ Nasim, K Witek, A Kincses, AY Abdin, E Żesławska, MA Marć, ...
New Journal of Chemistry 43 (15), 6021-6031, 2019
272019
Structural analysis and antimicrobial activity of 2 [1H]-pyrimidinethione/selenone derivatives
E Żesławska, I Korona-Głowniak, M Szczesio, A Olczak, A Żylewska, ...
Journal of Molecular Structure 1142, 261-266, 2017
252017
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH3 or 2-CH3
A Gunia-Krzyżak, D Żelaszczyk, A Rapacz, E Żesławska, ...
Bioorganic & Medicinal Chemistry 25 (2), 471-482, 2017
212017
N-[(2, 6-Dimethylphenoxy) alkyl] aminoalkanols—their physicochemical and anticonvulsant properties
AM Waszkielewicz, M Cegła, E Żesławska, W Nitek, K Słoczyńska, ...
Bioorganic & Medicinal Chemistry 23 (15), 4197-4217, 2015
202015
Computer-aided insights into receptor-ligand interaction for novel 5-arylhydantoin derivatives as serotonin 5-HT7 receptor agents with antidepressant activity
K Kucwaj-Brysz, R Kurczab, M Jastrzębska-Więsek, E Żesławska, ...
European Journal of Medicinal Chemistry 147, 102-114, 2018
182018
Anticonvulsant activity, crystal structures, and preliminary safety evaluation of N-trans-cinnamoyl derivatives of selected (un) modified aminoalkanols
A Gunia-Krzyżak, E Żesławska, K Słoczyńska, P Koczurkiewicz, W Nitek, ...
European Journal of Medicinal Chemistry 107, 26-37, 2016
162016
Chlorine substituents and linker topology as factors of 5-HT6R activity for novel highly active 1, 3, 5-triazine derivatives with procognitive properties in vivo
S Sudoł, K Kucwaj-Brysz, R Kurczab, N Wilczyńska, ...
European Journal of Medicinal Chemistry 203, 112529, 2020
152020
The selenium-nitrogen bond as basis for reactive selenium species with pronounced antimicrobial activity
J Rendekova, D Vlasakova, P Arsenyan, J Vasiljeva, MJ Nasim, K Witek, ...
Current Organic Synthesis 14 (8), 1082-1090, 2017
152017
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy) alkyl]-and N-{2-[2-(phenoxy) ethoxy] ethyl} aminoalkanols as anticonvulsant agents
AM Waszkielewicz, A Gunia-Krzyżak, B Powroźnik, K Słoczyńska, ...
Bioorganic & Medicinal Chemistry 24 (8), 1793-1810, 2016
152016
Seleno-vs. thioether triazine derivatives in search for new anticancer agents overcoming multidrug resistance in lymphoma
W Ali, S Garbo, A Kincses, M Nové, G Spengler, E Di Bello, ...
European Journal of Medicinal Chemistry 243, 114761, 2022
122022
The synthesis and crystal structures of the homologues of epalrestat
E Żesławska, W Nitek, W Tejchman
Journal of Chemical Crystallography 45, 151-157, 2015
122015
Phenylpiperazine 5,5-Dimethylhydantoin Derivatives as First Synthetic Inhibitors of Msr(A) Efflux Pump in Staphylococcus epidermidis
K Witek, G Latacz, A Kaczor, J Czekajewska, E Żesławska, A Chudzik, ...
Molecules 25 (17), 3788, 2020
112020
Pharmacophoric features for a very potent 5‐spirofluorenehydantoin inhibitor of cancer efflux pump ABCB 1, based on X‐ray analysis
E Żesławska, A Kincses, G Spengler, W Nitek, W Tejchman, J Handzlik
Chemical Biology & Drug Design 93 (5), 844-853, 2019
112019
Spectral Characteristic and Preliminary Anticancer Activity in vitro of Selected Rhodanine‐3‐carboxylic Acids Derivatives
I Stawoska, W Tejchman, O Mazuryk, A Lyčka, P Nowak‐Sliwinska, ...
Journal of Heterocyclic Chemistry 54 (5), 2889-2897, 2017
112017
Amiloride conformation: The effect of different crystalline environments
E Żesławska, B Oleksyn, K Stadnicka
Structural Chemistry 15, 567-571, 2004
112004
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20